FERMENTA BIOTECH LIMITED

Web: dil.net NSE: FERMENTA BSE: 506414 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

504 1(0%)

Volume

1L as on 23, Jun

Open

380

High

392

Low

380

502

VWAP

352

52 Week High

580

52 Week Low

249

Viand Research Rating

Quality Score

20/100

Growth Score

90/100

Valuation Score

50/100

Momentum Score

20/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,482

No. of Shares

2.94

P/E

138.45

P/B

3.42

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

2.47

ROCE

Profit Growth

Listing Date

Promoter Holding

64.08%

FII Holding

0.02%

DII Holding

Price Chart

Price Performance

1 Week10%

1 Month18%

3 Months11%

6 Months11%

1 Year11%

YTD11%

Moving Average

5 Day SMA335

10 Day SMA332

20 Day SMA323

30 Day SMA314

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	363	346	356	367
Resistance 2	356	345	350	357
Resistance 1	349	344	347	353
Pivot Point	342	343	342	344
Support 1	335	341	336	339
Support 2	328	340	333	330
Support 3	321	339	328	325

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 64.08%	(0.01) 64.08%	(0.01) 64.08%	(0.01) 64.08%	(2.01) 64.08%	(0.01) 62.06%	(0.01) 62.06%	(0.01) 62.06%	(0.01) 62.06%	(0.01) 62.06%	(0.01) 62.06%	(2.51) 62.06%	(0.01) 59.58%	(0.01) 59.58%	(0.01) 59.58%	(0.01) 59.58%	(0.01) 59.58%	(0.01) 59.58%
FIIs	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.02%	(0.01) 0.02%	(0.11) 0.05%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%	(0.01) 0.01%
DIIs	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-0.11) 0.00%	(0.01) 0.05%	(0.01) 0.05%	(0.01) 0.05%	(0.01) 0.05%
Public	33.32%	33.99%	34.75%	35.00%	35.00%	36.98%	36.41%	36.11%	36.05%	36.05%	36.04%	36.00%	38.46%	38.45%	38.38%	38.37%	38.37%	38.37%
No. of Shareholders	13,661	14,139	13,760	12,845	12,930	12,922	13,221	14,589	15,178	15,150	15,721	16,148	16,897	17,610	17,971	17,472	17,518	18,578

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	122	137	130	136	140	156	95	78	97	99	57	82	105	55	98	92	96	93	100
Sales Growth % (YoY)	-13.1%	-12.2%	37%	74.4%	43.7%	58.1%	67%	-5.2%	-7.4%	80.4%	-42%	-10.3%	9.4%	-40.9%	-1.8%	-16%	-3.4%	3%	7%
Sales Growth % (QoQ)	-10.9%	5.4%	-4.4%	-2.9%	-10.3%	64.2%	21.8%	-19.6%	-2%	73.7%	-30.5%	-21.9%	90.9%	-43.9%	6.5%	-4.2%	3.2%	-7%	-
Expenses	102	112	104	108	103	103	76	77	92	74	71	72	86	65	95	87	78	91	84
Operating Profit	20	25	27	28	37	53	19	1	5	25	-14	11	19	-10	3	5	18	2	16
OPM %	16	18	20	21	26	34	20	1	6	25	-24	13	18	-18	3	5	18	2	16
Other Income	14	1	5	9	4	2	3	3	5	3	-6	2	-8	-19	3	4	3	1	2
Interest	3	3	3	3	3	4	4	3	3	5	4	5	6	5	5	4	4	4	4
Depreciation	5	5	5	6	6	6	6	6	6	6	6	6	6	6	9	7	6	7	6
Profit before tax	26	17	24	28	32	45	12	-6	1	16	-29	2	-1	-41	-8	-2	10	-7	7
Tax %	29	31	25	23	-4	16	6	0	885	38	0	0	373	-8	6	8	21	13	42
Net Profit	19	12	18	22	33	38	11	-6	-7	10	-29	2	-5	-38	-8	-3	8	-8	4
Net Profit Growth % (QoQ)	58.3%	-33.3%	-18.2%	-33.3%	-13.2%	245.5%	283.3%	14.3%	-170%	134.5%	-1550%	140%	86.8%	-375%	-166.7%	-137.5%	200%	-300%	-
Net Profit Growth % (YoY)	-42.4%	-68.4%	63.6%	466.7%	571.4%	280%	137.9%	-400%	-40%	126.3%	-262.5%	166.7%	-162.5%	-375%	-300%	-	-	-	-
TTM Net Profit	71	85	111	104	76	36	8	-32	-24	-22	-70	-49	-54	-41	-11	1	4	-4	0
EPS in Rs	6.52	4.31	6.14	7.42	11.68	12.54	3.87	-1.98	-2.36	3.35	-9.7	0.62	-1.4	-12.7	-2.75	-0.88	2.61	-2.73	1.53

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	525	468	335	349	397	376	292	403	302	164	155	142	139	117
Sales Growth %	12.4%	39.5%	-3.9%	-12.2%	5.8%	28.8%	-27.7%	33.6%	84.2%	6%	9.2%	1.9%	19.2%	-1.8%
Expenses	426	352	307	330	335	293	225	248	209	152	134	126	113	94
Operating Profit	100	115	28	18	62	83	66	156	93	12	21	16	26	23
OPM %	19	25	8	5	16	22	23	39	31	7	13	11	19	20
Other Income	29	7	4	-20	8	8	12	6	9	3	1	0	3	2
Interest	12	15	17	21	18	19	20	21	14	10	6	4	5	5
Depreciation	22	24	25	28	26	20	15	12	12	10	8	9	10	9
Profit before tax	96	83	-10	-51	27	52	43	129	76	-6	7	3	14	10
Tax %	27	8	143	4	44	18	-37	8	28	49	61	67	24	36
Net Profit	70	76	-24	-53	15	43	60	117	46	-9	2	1	10	4
Net Profit Growth %	-7.9%	416.7%	54.7%	-453.3%	-65.1%	-28.3%	-48.7%	154.3%	611.1%	-550%	100%	-90%	150%	-
EPS in Rs	24.39	26.12	-7.84	-17.36	5.25	15.46	20.23	42.71	12.21	-4.14	-0.41	0.17	2.86	1.51
Dividend Payout %	15	9	-16	-7	23	16	24	1	2	-5	-51	249	29	124

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	93	41	105	116	43	63	34	90	59	2	4	15	14	23
Cash from Investing Activity	-43	0	-16	-55	-26	-41	-44	-97	-101	7	-13	-18	-25	-20
Cash from Financing Activity	-42	-51	-91	-41	-22	-1	-47	12	89	-12	10	1	13	-8
Net Cash Flow	8	-10	-1	19	-4	21	-57	6	47	-4	1	-2	2	-4

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	14	15	15	14	14	14	14	14	14	5	2	2	2	2	2	2
Reserves	392	376	348	276	274	301	358	346	295	246	122	142	128	129	130	125
Borrowings	113	112	115	125	139	220	239	232	224	209	173	87	89	71	65	43
Other Liabilities	128	149	137	125	120	102	96	94	80	92	87	75	70	60	61	55
Total Liabilities	648	651	614	539	548	637	707	687	614	551	385	307	288	262	259	226
Fixed Assets	220	219	227	258	269	267	299	263	200	178	177	172	168	85	87	94
CWIP	13	26	16	6	2	45	35	57	71	22	4	5	6	65	36	15
Investments	0	0	0	0	0	3	0	0	0	8	10	18	15	18	17	11
Other Assets	414	406	372	274	277	321	373	367	342	344	193	112	99	94	118	105
Total Assets	648	651	614	539	548	637	707	687	614	551	385	307	288	262	259	226

Delivery

Delivery Data: FERMENTA

#	Date	337 72% 580	Value (Cr)	Q/T 40	Del 37	Del 8
1	4-Sep	498	5	16	50	3
2	3-Sep	502	5	22	47	2
3	2-Sep	521	8	22	47	4
4	1-Sep	486	5	16	40	2
5	31-Aug	500	4	17	46	2
6	28-Aug	510	10	20	43	4
7	27-Aug	486	4	20	47	2
8	26-Aug	468	2	24	65	1
9	25-Aug	468	4	25	55	2
10	24-Aug	475	6	24	55	3
11	21-Aug	478	4	20	57	2
12	20-Aug	460	2	19	53	1
13	19-Aug	456	3	23	62	2
14	18-Aug	454	5	21	44	2
15	17-Aug	457	6	22	47	3
16	14-Aug	450	7	27	54	4
17	13-Aug	460	4	22	51	2
18	12-Aug	474	11	20	40	4
19	11-Aug	484	58	28	26	15
20	10-Aug	548	8	19	48	4
21	7-Aug	561	9	29	56	5
22	6-Aug	553	5	22	44	2
23	5-Aug	551	15	19	34	5
24	4-Aug	547	24	24	37	9
25	3-Aug	512	8	24	43	4
26	31-Jul	501	29	26	31	9
27	30-Jul	465	11	22	31	3
28	29-Jul	452	3	22	46	2
29	28-Jul	456	4	23	61	2
30	27-Jul	442	5	27	47	3
31	24-Jul	432	9	24	40	4
32	23-Jul	401	7	25	46	3
33	22-Jul	421	4	28	55	2
34	21-Jul	436	3	27	49	2
35	20-Jul	444	7	25	40	3
36	17-Jul	433	11	33	41	4
37	16-Jul	459	7	35	43	3
38	15-Jul	455	10	32	40	4
39	14-Jul	450	41	32	33	14
40	13-Jul	445	56	43	29	16
41	10-Jul	412	14	38	38	5
42	9-Jul	402	89	41	11	10
43	8-Jul	363	9	34	35	3
44	7-Jul	369	16	26	30	5
45	6-Jul	395	123	64	10	12
46	3-Jul	343	1	29	47	0
47	2-Jul	352	3	42	16	0
48	1-Jul	355	0	22	56	0
49	30-Jun	356	3	33	59	1
50	29-Jun	358	2	30	51	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	1,482c	13c	0.87
03-Sep	1,495c	15c	1.00
01-Sep	1,480c	19c	1.30
31-Aug	1,461c	61c	4.32
26-Aug	1,401c	26c	1.87
25-Aug	1,375c	17c	1.23
24-Aug	1,392c	12c	0.85
21-Aug	1,380c	39c	2.93
19-Aug	1,341c	4c	0.33
18-Aug	1,345c	5c	0.40
17-Aug	1,351c	27c	2.00
14-Aug	1,324c	47c	3.39
13-Aug	1,371c	23c	1.62
12-Aug	1,393c	275c	16.50
10-Aug	1,669c	61c	3.77
06-Aug	1,608c	24c	1.54
04-Aug	1,584c	115c	7.84
31-Jul	1,469c	112c	8.24
30-Jul	1,357c	32c	2.42
29-Jul	1,325c	12c	0.87
28-Jul	1,336c	43c	3.29
27-Jul	1,294c	19c	1.52
24-Jul	1,274c	0	0

Stock Checklist

Price is above from 52 week high low average: 77%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Aug26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.00%	-	0

FERMENTA BIOTECH LIMITED

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements